Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy.


Journal

Seminars in ultrasound, CT, and MR
ISSN: 1558-5034
Titre abrégé: Semin Ultrasound CT MR
Pays: United States
ID NLM: 8504689

Informations de publication

Date de publication:
Apr 2021
Historique:
entrez: 5 4 2021
pubmed: 6 4 2021
medline: 29 10 2021
Statut: ppublish

Résumé

The mechanisms by which tumors metastasize to bone are complex. Upon the successful establishment of metastatic deposits in the skeleton, detection of the disease becomes essential for therapeutic planning. The roles of CT, skeletal scintigraphy, SPECT/CT, MRI, PET/CT and PET/MRI will be reviewed. Therapeutic response criteria specifically designed to evaluate bone metastases (MD Anderson/MDA criteria) can guide image interpretation. Knowledge of therapeutic strategies such as systemic therapy with bisphosphonates or radiopharmaceuticals, radiation therapy, surgery, and percutaneous interventions such as vertebroplasty and radiofrequency ablation can help the radiologist produce reports that will provide maximum benefit to clinicians and patients.

Identifiants

pubmed: 33814103
pii: S0887-2171(20)30099-8
doi: 10.1053/j.sult.2020.08.016
pii:
doi:

Substances chimiques

Radiopharmaceuticals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-183

Informations de copyright

Published by Elsevier Inc.

Auteurs

Colleen M Costelloe (CM)

Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: ccostelloe@mdanderson.org.

Patrick P Lin (PP)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Hubert H Chuang (HH)

Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Behrang Amini (B)

Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.

Sudpreeda Chainitikun (S)

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Tse-Kuan Yu (TK)

Radiation Oncology, Houston Precision Cancer Center, Houston, TX.

Naoto T Ueno (NT)

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

William A Murphy (WA)

Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.

John E Madewell (JE)

Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH